Free Trial

Herbalife (NYSE:HLF) Downgraded to "Hold" Rating by Wall Street Zen

Herbalife logo with Retail/Wholesale background

Herbalife (NYSE:HLF - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Thursday.

HLF has been the subject of several other reports. Citigroup dropped their target price on Herbalife from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. DA Davidson upgraded shares of Herbalife from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $7.50 to $14.00 in a research note on Friday, March 21st. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $11.50.

Read Our Latest Report on Herbalife

Herbalife Stock Performance

Shares of Herbalife stock traded down $0.30 during trading hours on Thursday, hitting $6.67. The company's stock had a trading volume of 1,495,061 shares, compared to its average volume of 2,250,786. Herbalife has a twelve month low of $5.04 and a twelve month high of $12.79. The firm has a fifty day moving average of $7.28 and a 200-day moving average of $7.21. The stock has a market cap of $678.81 million, a price-to-earnings ratio of 2.68, a P/E/G ratio of 0.29 and a beta of 0.88.

Herbalife (NYSE:HLF - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.40 by $0.19. Herbalife had a negative return on equity of 20.78% and a net margin of 5.09%. The business had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the prior year, the company posted $0.49 EPS. The company's quarterly revenue was down 3.4% on a year-over-year basis. On average, sell-side analysts expect that Herbalife will post 1.57 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Juan Miguel Mendoza acquired 5,000 shares of the stock in a transaction dated Friday, May 2nd. The stock was acquired at an average cost of $6.73 per share, with a total value of $33,650.00. Following the completion of the transaction, the director now owns 140,000 shares in the company, valued at $942,200. This represents a 3.70% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders have acquired 17,500 shares of company stock worth $128,650 over the last three months. Company insiders own 1.73% of the company's stock.

Hedge Funds Weigh In On Herbalife

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Herbalife by 3.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company's stock worth $1,820,000 after buying an additional 6,747 shares in the last quarter. Empowered Funds LLC grew its position in shares of Herbalife by 12.9% during the first quarter. Empowered Funds LLC now owns 30,301 shares of the company's stock worth $261,000 after buying an additional 3,474 shares in the last quarter. Tenzing Global Management LLC acquired a new position in shares of Herbalife during the first quarter worth about $6,904,000. Parallax Volatility Advisers L.P. acquired a new position in shares of Herbalife during the first quarter worth about $790,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Herbalife by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company's stock worth $517,000 after buying an additional 2,523 shares in the last quarter.

About Herbalife

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

See Also

Should You Invest $1,000 in Herbalife Right Now?

Before you consider Herbalife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.

While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines